2018 annual financial data
Coherus Oncology 2018 Operating cash flow margin
Direct answer
Operating cash flow margin was -10,235.6%.
Operating income was -204,416,000 USD and net income was -209,339,000 USD.
Operating cash flow was -159,266,000 USD.
Get free Coherus Oncology email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,556,000 USD
- Operating income
- -204,416,000 USD
- Net income
- -209,339,000 USD
- Operating cash flow
- -159,266,000 USD